EXEL
Exelixis Inc
$58.85
0.00 (0.00%) Today
0.20 (0.34%) Pre-market
— up— down
Market Cap
$14.53B+44.6%
Revenue (TTM)
$2.36B+9.2%
Net Income (TTM)
$800.28M+52.7%
EPS (TTM)
3.18+52.7%
Shares Out
251.36M
251.36MP/E Ratio
16.65
16.65Forward P/E
15.62
15.62Open
$58.65
$58.65Previous Close
$58.65
$58.65Day Range
$57.53 – $59.13
$57.53 – $59.1352-Week Range
$33.76 – $59.72
$33.76 – $59.72Beta
0.48
0.48Volume
2.24M
2.24MAvg Volume
2.47M
2.47MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout EXEL
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.